Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial

BACKGROUND: Posttraumatic stress disorder (PTSD) is a severe psychiatric disease accompanied by neuroendocrine changes such as adrenergic overdrive and hence an elevated cardiovascular morbidity. Current pharmacotherapeutic options for PTSD are less than suboptimal, necessitating the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sack, M., Spieler, D., Wizelman, L., Epple, G., Stich, J., Zaba, M., Schmidt, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314583/
https://www.ncbi.nlm.nih.gov/pubmed/28209155
http://dx.doi.org/10.1186/s12916-017-0801-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314583/
https://www.ncbi.nlm.nih.gov/pubmed/28209155
http://dx.doi.org/10.1186/s12916-017-0801-0

Ejemplares similares